Bayer announced today that research on Xofigo® (radium Ra 223 dichloride) injection and darolutamide, the company's investigational oral androgen receptor (AR) antagonist, in prostate cancer will...

Smartlink Health Solutions, a leading provider of value-based health solutions for primary care clinics and Accountable Care Organizations (ACOs), today launched a technology refresh of the...

Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, announced today that Alan Ezekowitz, CEO...

BAKO is displaying some of their featured products at ISE ("Integrated Systems Europe"), which runs from February 6-9, 2018, and they are receiving positive feedback from clients. Many clients...

LendItFintech, the world's leading event in financial services innovation, today announced that Renaud Laplanche, founder and CEO of Upgrade, Inc., will join the keynote speaker roster for...